Insider Trading & Ownership - Hagan Joseph P

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hagan Joseph P
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2025-01-30
Purchase
2025-01-31
5:00 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
50,000 $1.0852 $54,260 1,610,808
(Direct)
View
2025-01-13
Sale
2025-01-15
5:00 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
127,054 $1.2632 $160,495 210,808
(Direct)
View
2024-01-18
Sale
2024-01-18
8:22 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
14,580 $1.1906 $17,359 57,112
(Direct)
View
2023-05-19
Sale
2023-05-23
5:18 pm
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
272 $10.58 $2,878 11,961
(Direct)
View
2022-01-26
Purchase
2022-01-26
4:13 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
100,000 $0.2152 $21,520 2,017,006
(Direct)
View
2022-01-03
Sale
2022-01-04
4:17 pm
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
40,000 $22.59 $903,650 13,500
(Direct)
View
2021-05-17
Sale
2021-05-17
7:13 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
4,186 $0.89 $3,726 316,292
(Direct)
View
2021-02-16
Sale(A)
2021-04-16
4:11 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
4,144 $1.72 $7,128 244,628
(Direct)
View
2021-02-16
Sale
2021-02-17
5:23 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
4,144 $1.72 $7,128 485,756
(Direct)
View
2020-11-16
Sale
2020-11-18
4:09 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
6,094 $0.5211 $3,176 215,994
(Direct)
View
2020-08-14
Sale
2020-08-17
8:22 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
4,245 $0.6049 $2,568 222,088
(Direct)
View
2020-05-15
Sale
2020-05-18
4:28 pm
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
4,426 $0.6267 $2,774 226,333
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-01-30
Option Award
2025-01-31
5:00 pm
N/A
2035-01-29
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
1,350,000 $0 1,610,808
(Direct)
View
2025-01-09
Option Award
2025-01-10
5:00 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
62,000 $1.3 337,862
(Direct)
View
2025-01-09
Option Award
2025-01-10
5:00 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
218,750 $1.36 337,862
(Direct)
View
2024-05-20
Option Award
2024-05-21
4:21 pm
N/A
2034-05-19
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
990,000 $0 990,000
(Direct)
View
2024-01-12
Option Award
2024-01-17
5:16 pm
N/A
2034-01-11
Regulus Therapeutics Inc. RGLS Hagan Joseph P
Chief Executive Officer
279,000 $0 320,692
(Direct)
View
2023-08-10
Option Award
2023-08-14
4:17 pm
N/A
2033-08-09
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
1,312,500 $0 1,312,500
(Direct)
View
2023-05-18
Exercise
2023-05-23
5:18 pm
2023-05-18
N/A
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
8,733 $0 11,961
(Direct)
View
2023-01-11
Option Award
2023-01-17
4:11 pm
N/A
2033-01-10
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
100,000 $0 100,000
(Direct)
View
2022-05-18
Option Award
2022-05-20
4:07 pm
N/A
N/A
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
23,345 $0 23,345
(Direct)
View
2022-05-10
Option Award
2022-05-11
4:54 pm
N/A
2030-01-20
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
300,000 $0 300,000
(Direct)
View
2022-01-12
Option Award
2022-01-26
4:13 pm
N/A
2032-01-11
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
1,600,000 $0 2,017,006
(Direct)
View
2022-01-03
Exercise
2022-01-04
4:17 pm
N/A
2028-02-08
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
40,000 $0 13,500
(Direct)
View
2022-01-03
Exercise
2022-01-04
4:17 pm
N/A
N/A
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
40,000 $5.08 13,500
(Direct)
View
2021-06-14
Option Award
2021-06-16
9:23 pm
N/A
2031-06-14
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
31,347 $0 31,347
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:31 pm
N/A
2031-06-09
Zosano Pharma Corp ZSAN Hagan Joseph P
Director
45,000 $0 52,500
(Direct)
View
2021-04-14
Conversion
2021-04-16
4:12 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
83,435 $0 320,478
(Indirect)
View
2021-02-04
Option Award
2021-02-05
5:01 pm
N/A
2031-02-04
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
600,000 $0 600,000
(Direct)
View

Ownership
2021-01-04
5:56 pm
N/A
N/A
Aurinia Pharmaceuticals Inc. AUPH Hagan Joseph P
Director
0 $0 128,500
(Direct)
View
2020-12-04
Option Award
2020-12-07
4:22 pm
2020-12-04
2025-12-04
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
29,760 $0.125 255,434
(Indirect)
View
2020-12-04
Option Award
2020-12-07
4:22 pm
N/A
N/A
Regulus Therapeutics Inc. RGLS Hagan Joseph P
President and CEO
39,680 $0.6301 255,434
(Indirect)
View
2020-06-25
Option Award
2020-06-29
9:54 pm
N/A
N/A
Zosano Pharma Corp ZSAN Hagan Joseph P
Director
7,500 $0 7,500
(Direct)
View
2020-06-03
Option Award
2020-06-05
5:05 pm
N/A
2030-06-02
Zosano Pharma Corp ZSAN Hagan Joseph P
Director
15,000 $0 15,000
(Direct)
View
(A) Indicate amendment filing.